New Enterprise Associates 12, Limited Partnership's Net Worth

$1.15 Billion

Estimate Recalculated Feb 22, 2024 06:34PM EST

Who is New Enterprise Associates 12, Limited Partnership?

New Enterprise Associates 12, Limited Partnership has an estimated net worth of $1.15 Billion. This is based on reported shares across multiple companies, which include OPOWER, INC., Workday, Inc., FUSION-IO, INC., TriVascular Technologies, Inc., HYPERION THERAPEUTICS INC, CHANNELADVISOR CORP, Groupon, Inc., Zosano Pharma Corp, Tintri, Inc., TREVENA INC, PROTEOSTASIS THERAPEUTICS, INC., ARDELYX, INC., SUNESIS PHARMACEUTICALS INC, Liquidia Technologies Inc, PEPLIN INC, ARYx Therapeutics, Inc., HEMOSENSE INC, and Echo Global Logistics, Inc..

SEC CIK

New Enterprise Associates 12, Limited Partnership's CIK is 0001383391

Past Insider Trading and Trends

2014 was New Enterprise Associates 12, Limited Partnership's most active year for acquiring shares with 22 total transactions. New Enterprise Associates 12, Limited Partnership's most active month to acquire stocks was the month of June. 2014 was New Enterprise Associates 12, Limited Partnership's most active year for disposing of shares, totalling 35 transactions. New Enterprise Associates 12, Limited Partnership's most active month to dispose stocks was the month of June. 2015 saw New Enterprise Associates 12, Limited Partnership paying a total of $23,518,351.15 for 2,794,565 shares, this is the most they've acquired in one year. In 2015 New Enterprise Associates 12, Limited Partnership cashed out on 2,384,221 shares for a total of $109,674,166.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

OPOWER, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-8.99M
$10.30
-$92,594,589.80
0
Jun 14
Form 4
8.99M
8.99M
Apr 9
Form 3
0
0
No matching records found

TriVascular Technologies, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.94M
0
Feb 3
Form 4
3.94M
$12.00
$6,999,996.00
3.94M
Apr 22
Form 3
0
0
No matching records found

Zosano Pharma Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-53.59%
-1.10M
$2.01
-$2,211,431.96
952.81K
Feb 13
Form 4
-0.36%
-7.47K
$0.75
-$5,603.25
2.05M
Sep 16
Form 4
-0.48%
-10.00K
$0.74
-$7,400.00
2.06M
Sep 13
Form 4
-2.36%
-50.00K
$1.01
-$50,440.00
2.07M
Aug 29
Form 4
-0.06%
-1.20K
$1.21
-$1,452.00
2.12M
Aug 24
Form 4
-1.10%
-23.68K
$1.27
-$30,132.20
2.12M
Jul 19 - Jul 21
Form 4
-0.62%
-13.38K
$1.20
-$16,059.74
2.15M
Jul 13
Form 4
+20.33%
364.66K
$9.46
$3,448,256.35
2.16M
Jan 30
Form 3
0
0
No matching records found

Tintri, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Feb 26
Form 4
5.25M
$7.00
$6,485,003.00
5.25M
Jul 6
Form 3
0
0
No matching records found

TREVENA INC (TRVN) Snapshot price: $0.577

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+26.24%
1M
$4.00
$4,000,000.00
4.81M
Dec 10
Form 4
3.81M
$7.00
3.81M
Feb 5
Form 3
0
0
No matching records found